The use of additional adjuvant therapy beyond initial treatment has greatly improved outcomes and reduced the risk of disease recurrence for high-risk patients with melanoma. While there is a consensus regarding the use of ...
Aug 23, 2022
0
6
Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that initial treatment with the PARP inhibitor veliparib in combination with chemotherapy significantly increased progression-free ...
Sep 28, 2019
0
6
A review by the American College of Physicians (ACP) of performance measures designed to evaluate quality of care for those suffering from major depressive disorder found only 1 of 8 measures relevant to internal medicine ...
Mar 5, 2024
0
1
Associate Professor Anthony Leicht was part of an international group led by Professor John Saxton from Northumbria University and the University of East Anglia that studied how exercise might help prostate cancer sufferers ...
Mar 11, 2020
0
2
A combination of pretherapy imaging and dosimetry can help ensure that patients with refractory differentiated thyroid cancer obtain the maximum benefit from radioactive iodine treatments following redifferentiation therapy. ...
Jun 22, 2023
0
4
The National Institute for Health and Care Excellence (NICE) has not recommended a new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma on the NHS in England.
Mar 12, 2020
0
1
Up to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene mutation, which is associated with a high risk of relapse and a very poor prognosis. But clinical studies have shown that drugs called ...
Feb 8, 2024
0
0
Children and young people in the UK with cancers that have come back can now access new personalized treatments quicker than ever before thanks to a national tumor biopsy sequencing platform and clinical trial funded by Cancer ...
Sep 4, 2020
0
5
Many cancer survivors with high medical copayments experience financial toxicity, an economic side effect of cancer treatment.
May 6, 2020
0
1
Adding corticosteroids to standard intravenous (IV) immunoglobulin treatment for children with Kawasaki disease judged to be at higher risk of developing blood vessel complications made initial treatment more successful and ...
Aug 19, 2020
0
11
